fingolimod hydrochloride has been researched along with Bone Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, T; Ohama, T; Sato, K; Tsuji, S | 1 |
1 other study(ies) available for fingolimod hydrochloride and Bone Cancer
| Article | Year |
|---|---|
Efficacy of an anti-cancer strategy targeting SET in canine osteosarcoma.
Topics: Animals; Anticarcinogenic Agents; Bone Neoplasms; Calcineurin Inhibitors; Cell Line, Tumor; Cisplatin; Dogs; Drug Synergism; Fingolimod Hydrochloride; Osteosarcoma; Protein Phosphatase 2; Signal Transduction | 2019 |